ARCTIC BIOSCIENCE NK -10
Research ARCTIC BIOSCIENCE NK -10 (9TD) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- Ticker9TD
- ExchangeF
- CurrencyEUR
- Financial periodFY2025
- RevenueEUR 40.10M
- Revenue growth-7.8%
- Net income-EUR 41.03M
- Free cash flow-EUR 45.40M
- Gross margin27.5%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 40.10M | -EUR 41.03M | -EUR 45.40M | 27.5% | -1.52 | EUR 218.12K | EUR 63.34M | EUR 173.49M |
| FY2024 | EUR 43.48M | -EUR 47.93M | -EUR 96.17M | 27.3% | -1.89 | EUR 2.16M | EUR 32.86M | EUR 210.73M |
| FY2023 | EUR 33.75M | -EUR 45.51M | -EUR 65.07M | 29.0% | -1.79 | EUR 78.47M | EUR 5.58M | EUR 258.56M |
| FY2022 | EUR 34.27M | -EUR 34.02M | -EUR 83.96M | 34.0% | -1.39 | EUR 143.16M | EUR 1.10M | EUR 287.28M |
| FY2021 | EUR 21.52M | -EUR 42.58M | -EUR 76.00M | 24.0% | -1.75 | EUR 225.13M | EUR 1.27M | EUR 320.55M |